Vaccines, epidemics, pandemics and us

Journal of the American Dental Association

Volumn 137, Issue 6, 2006, Pages 706-708

  Glick, Michael ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33745745612     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2006.0269     Document Type: Editorial

References (5)

1. U.S. Public Health Service, Centers for Disease Control and Prevention. Mumps epidemic: United Kingdom, 2004-2005. MMWR Morb Mortal Wkly Rep 2006;55:173-5.
2. U.S. Public Health Service, Centers for Disease Control and Prevention. Exposure to mumps during air travel (published correction appears in MMWR Morb Mortal Wkly Rep 2006;55:434). MMWR Morb Mortal Wkly Rep 2006;55:1-2.
3. Treanor JJ, Campbell JD, Zangwill KM, Rowe T, Wolff M. Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N Engl J Med 2006;354:1343-51.
4. Hehme N, Engelmann H, Kunzel W, et al. Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines. Med Microbiol Immunol (Berl) 2002;191:203-8.
5. Stephenson I, Bugarini R, Nicholson KG, et al. Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF 59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy. J Infect Dis 2005;191:1210-5.